Biologics for psoriasis: is there any unmet need left?

Expert Opin Biol Ther. 2022 Dec;22(12):1429. doi: 10.1080/14712598.2022.2155356.

Authors

Steven R Feldman^{1

2

3}, Alan M Menter³

Affiliations

¹ Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem.
² Department of Pathology, Wake Forest University School of Medicine, Winston-Salem.
³ Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem.

PMID: 36461935
DOI: 10.1080/14712598.2022.2155356

No abstract available

Keywords: Biologics; biosimilars; dermatology; efficacy; psoriasis; psoriatic arthritis; safety; treatment.

Publication types

Editorial

MeSH terms

Arthritis, Psoriatic*
Biological Products* / adverse effects
Humans
Psoriasis* / drug therapy

Substances

Biological Products